{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-009154","form_type":"8-K","ticker":"BIAF","cik":"0001712762","company_name":"bioAffinity Technologies, Inc.","filed_at":"2026-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.978479+00:00","generated_at":"2026-05-15T18:49:15.728521+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Two directors not standing for re-election at bioAffinity Technologies' 2026 annual meeting","bullets":["Robert Anderson and Roby Joyce informed the board on March 5, 2026 of their decisions not to stand for re-election.","Their terms expire at the Annual Meeting currently scheduled for April 30, 2026.","The decisions did not result from any disagreements with the company on operations, policies, or practices."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-009154","json":"https://secwatch.observer/filing/0001493152-26-009154.json","markdown":"https://secwatch.observer/filing/0001493152-26-009154.md","text":"https://secwatch.observer/filing/0001493152-26-009154.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1712762/000149315226009154/0001493152-26-009154-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1712762/000149315226009154/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T18:49:15.728521+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}